Lawrence Rice

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. ncbi request reprint Delayed-onset heparin-induced thrombocytopenia
    Lawrence Rice
    Baylor College of Medicine, The Methodist Hospital, and St Luke s Episcopal Hospital, 6565 Fannin Street, MS 902 Main, Suite 930, Houston, TX 77030, USA
    Ann Intern Med 136:210-5. 2002
  2. ncbi request reprint Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital
    Sandeep Kodityal
    Baylor College of Medicine, Houston, TX, USA
    J Intensive Care Med 21:86-92. 2006
  3. ncbi request reprint Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia
    Lawrence Rice
    The Methodist Hospital, Weill Cornell Medical College, Houston, Texas, USA
    J Clin Pharmacol 47:1028-34. 2007
  4. doi request reprint The role of beta-catenin in chronic myeloproliferative disorders
    Monica P Jauregui
    Pathology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX 77030, USA
    Hum Pathol 39:1454-8. 2008
  5. ncbi request reprint Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes
    Lawrence Rice
    Baylor College of Medicine, 6565 Fannin, MS 902, Houston, TX 77030, USA
    Postgrad Med 112:85-9. 2002
  6. ncbi request reprint Current management of the myeloproliferative disorders: a case-based review
    Lawrence Rice
    Department of Medicine Hematology Oncology Section, Baylor College of Medicine, Houston, Tex 77030, USA
    Arch Pathol Lab Med 130:1151-6. 2006
  7. ncbi request reprint Evolving management strategies for heparin-induced thrombocytopenia
    Lawrence Rice
    Baylor College of Medicine, Texas Medical Center, Houston, TX, USA
    Semin Hematol 42:S15-21. 2005
  8. ncbi request reprint The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations
    Lawrence Rice
    Hematology Oncology Section, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Cell Physiol Biochem 15:245-50. 2005
  9. ncbi request reprint Drug evaluation: AMG-531 for the treatment of thrombocytopenias
    Lawrence Rice
    Baylor College of Medicine, Houston, TX 77030, USA
    Curr Opin Investig Drugs 7:834-41. 2006
  10. ncbi request reprint Cases of heparin-induced thrombocytopenia elucidate the syndrome
    Lawrence Rice
    Department of Medicine, Baylor College of Medicine, 6565 Fannin, MS 902, Room 930, Houston, TX 77030, USA
    Chest 127:21S-6S. 2005

Collaborators

Detail Information

Publications43

  1. ncbi request reprint Delayed-onset heparin-induced thrombocytopenia
    Lawrence Rice
    Baylor College of Medicine, The Methodist Hospital, and St Luke s Episcopal Hospital, 6565 Fannin Street, MS 902 Main, Suite 930, Houston, TX 77030, USA
    Ann Intern Med 136:210-5. 2002
    ..Heparin-induced thrombocytopenia presents 5 to 12 days after heparin exposure, with or without arterial or venous thromboemboli. Delayed recognition and treatment of heparin-induced thrombocytopenia contribute to poor patient outcomes...
  2. ncbi request reprint Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital
    Sandeep Kodityal
    Baylor College of Medicine, Houston, TX, USA
    J Intensive Care Med 21:86-92. 2006
    ..In contemporary "real world" use, argatroban provides safe and effective anticoagulation, strengthening the mandate to initiate alternative anticoagulation whenever heparin-induced thrombocytopenia appears likely...
  3. ncbi request reprint Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia
    Lawrence Rice
    The Methodist Hospital, Weill Cornell Medical College, Houston, Texas, USA
    J Clin Pharmacol 47:1028-34. 2007
  4. doi request reprint The role of beta-catenin in chronic myeloproliferative disorders
    Monica P Jauregui
    Pathology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX 77030, USA
    Hum Pathol 39:1454-8. 2008
    ..In addition, beta-catenin may be a useful marker for differentiating polycythemia vera and essential thrombocythemia from other types of chronic myeloproliferative disorders...
  5. ncbi request reprint Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes
    Lawrence Rice
    Baylor College of Medicine, 6565 Fannin, MS 902, Houston, TX 77030, USA
    Postgrad Med 112:85-9. 2002
    ..Use of alternative anticoagulants is improving patient outcomes. Lepirudin, argatroban, and danaparoid each have advantages and disadvantages; treatment should be tailored to each patient...
  6. ncbi request reprint Current management of the myeloproliferative disorders: a case-based review
    Lawrence Rice
    Department of Medicine Hematology Oncology Section, Baylor College of Medicine, Houston, Tex 77030, USA
    Arch Pathol Lab Med 130:1151-6. 2006
    ..The cytoreductive agent of choice for these disorders is currently hydroxyurea, emerging from randomized trials beginning with those of the Polycythemia Vera Study Group...
  7. ncbi request reprint Evolving management strategies for heparin-induced thrombocytopenia
    Lawrence Rice
    Baylor College of Medicine, Texas Medical Center, Houston, TX, USA
    Semin Hematol 42:S15-21. 2005
    ..Because of its favorable pharmacologic characteristics, the DTI bivalirudin has been successfully employed in HIT, particularly in patients with multiorgan failure...
  8. ncbi request reprint The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations
    Lawrence Rice
    Hematology Oncology Section, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Cell Physiol Biochem 15:245-50. 2005
    ..Ongoing studies to identify the molecular targets and cytokine intermediaries should facilitate detection, dissection and eventual therapeutic manipulation of the process...
  9. ncbi request reprint Drug evaluation: AMG-531 for the treatment of thrombocytopenias
    Lawrence Rice
    Baylor College of Medicine, Houston, TX 77030, USA
    Curr Opin Investig Drugs 7:834-41. 2006
    ..A Japanese phase II ITP study has been initiated, as has a phase II trial of MDS patients in the US and France...
  10. ncbi request reprint Cases of heparin-induced thrombocytopenia elucidate the syndrome
    Lawrence Rice
    Department of Medicine, Baylor College of Medicine, 6565 Fannin, MS 902, Room 930, Houston, TX 77030, USA
    Chest 127:21S-6S. 2005
    ..The potential beneficial impact of therapy with direct thrombin inhibitors makes it more important to maintain awareness of and vigilance for this syndrome...
  11. ncbi request reprint Every case of essential thrombocythemia should be tested for the Philadelphia chromosome
    Lawrence Rice
    Department of Medicine, Hematology Oncology Section, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Am J Hematol 78:71-3. 2005
    ..We conclude that CML can present in identical fashion as ET. The mandate for routine Philadelphia chromosome testing is magnified by the availability of targeted therapy and its greater efficacy in early stage disease...
  12. ncbi request reprint Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient)
    Lawrence Rice
    Section of Hematology Oncology, Baylor College of Medicine, 6565 Fannin St, MS 902, Room 930, Houston, TX 77030, USA
    Arch Intern Med 164:1961-4. 2004
  13. ncbi request reprint Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass
    L Rice
    Section of Hematology, Department of Medicine, Baylor College of Medicine, 6565 Fannin, MS 902 Main, Houston, TX 77030, USA
    Ann Intern Med 134:652-6. 2001
    ..Studies of space-flight anemia have uncovered a physiologic process, neocytolysis, by which young red blood cells are selectively hemolyzed, allowing rapid adaptation when red cell mass is excessive for a new environment...
  14. ncbi request reprint Modulation of red cell mass by neocytolysis in space and on Earth
    L Rice
    Section of Hematology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Pflugers Arch 441:R91-4. 2000
    ..Thus, unraveling a problem for space travelers has uncovered a physiologic process controlling the red cell mass that can be applied to human disorders on Earth...
  15. ncbi request reprint Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures
    Sandeep Kodityal
    The Department of Medicine, Section of Hematology, Baylor College of Medicine, Houston, TX, USA
    Eur J Haematol 71:109-13. 2003
    ..The first effective agent for this purpose may be danaparoid, a less-sulfated low molecular weight heparinoid. Recently, direct thrombin inhibitors have been used...
  16. doi request reprint Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition
    Jianguo Wen
    Department of Pathology, The Methodist Hospital and Research Institute, Houston, TX 77030, USA
    Leuk Res 34:85-92. 2010
    ..The results suggest the opportunity for using p38 MAPK inhibition to enhance the efficacy of ATO+bortezomib in myeloma...
  17. ncbi request reprint Heparin-induced thrombocytopenia in the cardiac patient: 10 points to help the physician
    Lawrence Rice
    Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, Texas, USA
    Methodist Debakey Cardiovasc J 7:6-9. 2011
    ..The patient demanded transfer to our hospital. His subsequent course was benign, including transition to warfarin and discontinuation of anticoagulants after 6 months...
  18. ncbi request reprint Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia
    Martha P Mims
    Department of Medicine, Section of Hematology Oncology, Baylor College of Medicine, 6565 Fannin, Houston, TX 77030, USA
    Eur J Haematol 72:366-9. 2004
    ..Heparin has rarely been reported to cause acute cardiorespiratory reactions or collapse. Some reports relate this to underlying heparin-induced thrombocytopenia...
  19. doi request reprint PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit
    MATTHEW WANAT
    Department of Pharmacy, The Methodist Hospital, Houston, TX 77030
    Clin Appl Thromb Hemost 19:297-302. 2013
    ..Unwarranted ordering and incorrect interpretation of heparin antibody tests can expose a patient to adverse drug events and imposes a significant economic burden on our health care system...
  20. doi request reprint p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes
    Munir Shahjahan
    Department of Pathology, Methodist Hospital and Methodist Research Institute, Houston, TX, USA
    Am J Clin Pathol 130:635-41. 2008
    ..007) cases. Increased p38 MAPK activation may have a role in inhibiting hematopoiesis leading to cytopenias in MDS, and relatively decreased p38 activation in MPD might promote hematopoiesis, resulting in cytosis...
  21. ncbi request reprint Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia
    Abhay F Srinivasan
    Section of Hematology Oncology, Department of Medicine, Baylor College of Medicine, Houston, Tex 77030, USA
    Arch Intern Med 164:66-70. 2004
    ..With HIT, it has been suggested that unopposed warfarin can precipitate venous limb gangrene. There are also reports of warfarin-induced skin necrosis. We seek to confirm and increase awareness of the risks of warfarin with HIT...
  22. ncbi request reprint Introduction. What's happening with heparin-induced thrombocytopenia: emerging preventive, diagnostic, and management strategies
    Lawrence Rice
    Baylor College of Medicine, Texas Medical Center, USA
    Semin Hematol 42:S1-2. 2005
  23. ncbi request reprint Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study
    Arsalan Ahmed
    The Department of Pathology and Laboratory Medicine, The Methodist Hospital and Research Institute, Houston, TX 77030, USA
    Pathol Res Pract 205:634-8. 2009
    ..Further studies are warranted to confirm our observation and to study the mechanisms by which mast cells contribute to fibrosis in the MPN setting...
  24. ncbi request reprint Necrobiotic xanthogranuloma with posterior scleritis
    Kirk R Wilhelmus
    Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
    Arch Ophthalmol 124:748. 2006
  25. ncbi request reprint Erythropoietin withdrawal alters interactions between young red blood cells, splenic endothelial cells, and macrophages: an in vitro model of neocytolysis
    J Trial
    Department of Medicine, Baylor College of Medicine, and Veterans Affairs Medical Center, Houston, Tex 77030 4211, USA
    J Investig Med 49:335-45. 2001
    ....
  26. ncbi request reprint Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interface
    J Trial
    Department of Medicine, Baylor College of Medicine and the Veterans Affairs Medical Center, Houston, Texas 77030 4211, USA
    Curr Pharm Des 10:183-90. 2004
    ..New erythropoietin products and methods of administration avoid the intermittent rapid decreases associated with the stimulus for neocytolysis, but study of this phenomenon may yield further improvements in drug design...
  27. ncbi request reprint Neocytolysis contributes to the anemia of renal disease
    L Rice
    Methodist Hospital, Houston, TX, USA
    Am J Kidney Dis 33:59-62. 1999
    ..One implication is the prediction that intravenous bolus EPO therapy is metabolically and economically inefficient compared with lower doses administered more frequently subcutaneously...
  28. pmc The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis
    Randall J Olsen
    Department of Pathology and Laboratory Medicine, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX, USA
    J Hematop 1:111-7. 2008
    ..Our results suggest that JAK2 ( V617F ) allele evaluation can be a useful ancillary test for discriminating MDS from MPN in specimens with bone marrow fibrosis...
  29. pmc The amyloidoses: clinical features, diagnosis and treatment
    Kelty R Baker
    Baylor College of Medicine, Houston, TX, USA
    Methodist Debakey Cardiovasc J 8:3-7. 2012
    ..The following paper describes the various types and clinical features of amyloidosis and provides an overview of current diagnostic tools and therapies...
  30. ncbi request reprint Laparoscopic splenectomy for chronic recurrent thrombotic thrombocytopenic purpura
    Francis A Essien
    Michael E DeBakey Department of Surgery, Baylor College of Medicine, The Methodist Hospital, Houston, Texas 77030, USA
    Surg Laparosc Endosc Percutan Tech 13:218-21. 2003
    ..The inherent benefits of the minimally invasive approach, its low morbidity, short hospital stay, and faster recovery, are significant advantages for these patients...
  31. doi request reprint Argatroban therapy in heparin-induced thrombocytopenia
    Lawrence Rice
    Chief of Hematology, The Methodist Hospital and Professor of Medicine, Cornell Weill Medical College 6550 Fannin, Suite 1001, Houston, TX 77030, USA
    Expert Rev Clin Pharmacol 1:357-67. 2008
    ..In patients undergoing PCI, argatroban with or without glycoprotein IIb/IIIa inhibition leads to high rates of procedural success with low bleeding risk. Herein we review argatroban therapy for HIT and for PCI. ..
  32. pmc "Surgical" abdomen in a patient with chronic lymphocytic leukemia: a case of acquired angioedema
    Moonjung Jung
    Department of Medicine, The Methodist Hospital, Weill Cornell Medical College, Houston, TX 77030, USA
    J Gastrointest Surg 15:2262-6. 2011
    ..This disorder is strongly associated with chronic lymphocytic leukemia (CLL) and other indolent lymphoplasmacytic disorders...
  33. doi request reprint Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia
    Moonjung Jung
    Department of Medicine, The Methodist Hospital, Weill Cornell Medical College, Houston, TX 77030, USA
    Clin Lymphoma Myeloma Leuk 11:S10-3. 2011
    ..More awareness of the association of CLL with these complications could facilitate earlier diagnosis and effective treatment...
  34. ncbi request reprint A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study
    Steven W Boyce
    Washington Hospital Center, Washington, DC 20815 6048, USA
    Am J Ther 18:14-22. 2011
    ..The average medication cost per course of treatment was $1688 for desirudin and $8250 for argatroban. Desirudin warrants further study as a potentially cost-effective alternative to argatroban in patients with suspected HIT...
  35. ncbi request reprint Limb amputation in hemoglobin SC disease after application of ice and elevation
    Sadia Saleem
    Hematology Oncology Section, Department of Medicine, Baylor College of Medicine, Houston, Texas
    Am J Hematol 82:53-4. 2007
    ..Vasoocclusion of the extremities to the point of gangrene is rarely reported in sickle cell disorders, and this case highlights the dangers of measures limiting blood flow in such patients...
  36. doi request reprint P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells
    Jianguo Wen
    Department of Pathology, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX, USA
    Br J Haematol 140:169-80. 2008
    ..These results suggest that ATO-induced p38 MAPK activation plays an important role in the resistance to ATO in myeloma cells and that p38 MAPK inhibition may overcome resistance to ATO treatment in myeloma patients...
  37. ncbi request reprint Acute respiratory distress syndrome after rituximab infusion
    Alberto J Montero
    Section of Hematology Oncology, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Hematol 82:324-6. 2005
    ..ARDS is rarely associated with rituximab infusion for lympho-proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops severe pulmonary symptoms soon after infusion...
  38. ncbi request reprint Pathologic quiz case: a 64-year-old man with hematuria, intracranial hemorrhage, and severe coagulation abnormalities. Long-acting warfarin-like rodenticide toxicity
    Dax Kurbegov
    Department of Medicine, Section of Hematology Oncology, Baylor College of Medicine at The Methodist Hospital, Houston, Tex 77030, USA
    Arch Pathol Lab Med 128:e181-2. 2004
  39. ncbi request reprint Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia
    Ettore Biagi
    Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital, Houston, Texas 77030, USA
    Clin Cancer Res 11:6916-23. 2005
    ..Human interleukin-2 further potentiates the immunogenicity of human CD40 ligand in preclinical murine models...
  40. ncbi request reprint Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopen
    E Magnus Ohman
    Division of Cardiology, Division of Hematology, and School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599 7075, USA
    J Thromb Thrombolysis 19:11-9. 2005
    ..Both HIT and HITT are associated with high morbidity and mortality and represent substantial worldwide public health concerns...
  41. doi request reprint Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy
    Gustavo B F Oliveira
    Duke Clinical Research Institute, Duke University Medical Center, 2400 Pratt St, Durham, NC 27705, USA
    Arch Intern Med 168:94-102. 2008
    ..Despite widespread heparin use in clinical practice, the associated development of thrombocytopenia is an underrecognized and undertreated complication...
  42. doi request reprint Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
    David J Kuter
    Massachusetts General Hospital, Boston, MA 02114, USA
    Lancet 371:395-403. 2008
    ..We assessed the long-term administration of romiplostim in splenectomised and non-splenectomised patients with ITP...
  43. ncbi request reprint Trousseau-like venous thromboemboli with benign ovarian tumors
    Nicolas R Cazap
    Thromb Haemost 91:822-3. 2004